[
  {
    "ts": "2025-11-21T07:11:55+00:00",
    "headline": "Exclusive AI-Designed Protein Access Might Change the Case for Investing in Bio-Techne (TECH)",
    "summary": "Bio-Techne recently announced a licensing agreement with Monod Bio, granting it exclusive commercial rights to a subset of AI-designed NovoBody™ Duo molecules for use in research and next-generation diagnostics. This collaboration expands Bio-Techne's recombinant protein and diagnostics portfolio and strengthens its position at the forefront of AI-powered precision medicine innovation. We'll explore how gaining exclusive access to cutting-edge AI-designed protein technologies could influence...",
    "url": "https://finance.yahoo.com/news/exclusive-ai-designed-protein-access-071155852.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "6e54d9e7-c8a6-3891-ba0f-8bcca635b220",
      "content": {
        "id": "6e54d9e7-c8a6-3891-ba0f-8bcca635b220",
        "contentType": "STORY",
        "title": "Exclusive AI-Designed Protein Access Might Change the Case for Investing in Bio-Techne (TECH)",
        "description": "",
        "summary": "Bio-Techne recently announced a licensing agreement with Monod Bio, granting it exclusive commercial rights to a subset of AI-designed NovoBody™ Duo molecules for use in research and next-generation diagnostics. This collaboration expands Bio-Techne's recombinant protein and diagnostics portfolio and strengthens its position at the forefront of AI-powered precision medicine innovation. We'll explore how gaining exclusive access to cutting-edge AI-designed protein technologies could influence...",
        "pubDate": "2025-11-21T07:11:55Z",
        "displayTime": "2025-11-21T07:11:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0Ih9Jyeb4E8RAOq22ZtFHA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r5jgPUxQrxmcesBmGBKgkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/exclusive-ai-designed-protein-access-071155852.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/exclusive-ai-designed-protein-access-071155852.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]